Trademark Search  /  CTX213

CTX213

● Live · Pending

U.S. federal trademark · Serial No. 98955696

Mark
CTX213
Status
Pending
Serial Number
98955696
Filing Date
January 13, 2025
Class(es)
Class 005, Class 042

Owners

CRISPR Therapeutics AG
25 · ZUG V8, CH
CRISPR Therapeutics AG
25 · ZUG V8, CH

Goods & Services

gene editing, namely, pharmaceutical research and development in the field of stem cell therapy for the treatment of diabetes; Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of stem cell therapy for the treatment of diabetes

Cells for medical or clinical use in the field of stem cell therapy for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes; pharmaceutical and biopharmaceutical agents for the treatment of diabetes

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "CTX213" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.